and licensed by Eli Lilly in 2018
Both are common among patients with diabetes and obesity, yet until recently, treatment options were mostly limited to lifestyle interventions or devices like continuous positive airway pressure (CPAP) machines
10.1007/s11011-014-9627-z 57 ShevchoukO
For example, in this study, liraglutide helped people lose almost 13 pounds more than a placebo over 1 year, and over 2 years, it reduced the prevalence of prediabetes by 52% and metabolic syndrome by 59%
Better weight control may be achieved if adequately intensive lifestyle changes are implemented and monitored in the T2D population treated with SGLT2is
Quick facts (30 seconds) If you're trying to make a switch (or even just thinking about it), the most helpful thing you can do today is keep clean records Healthcount is built for food, exercise, measurements, progress photos, and Mounjaro dosing logs